Press Releases

SAN DIEGO, Feb. 6, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its third quarter fiscal year 2020, ended December 31, 2019, at 4:15pm Eastern time on Monday, Febru

SEATTLE and VANCOUVER, British Columbia, Feb. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it has retained the FreeMind Group, an inte

SAN DIEGO, Feb. 6, 2020 /PRNewswire/ -- Epic Sciences, Inc. announced today it will present two abstracts at the 2020 American Society of Clinical Oncology Genito

CAMBRIDGE, Mass., Feb. 6, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its New Drug Application (NDA) see

SAN DIEGO, Feb. 6, 2020 /PRNewswire/ -- Histogen Inc., a regenerative medicine company with a unique biological platform that replaces and regenerates tissues in the body, announced today that it will be featured as a presenting company at the BIO CEO & Investor Conference taking place February 10-11, 2020 at the New York Marriott

SAN DIEGO, Feb. 6, 2020 /PRNewswire/ -- IQ4I Research & Consultancy published a new report on "Molecular Diagnostics Global Market – Forecast To 2026" .

BASEL, Switzerland, Feb. 6, 2020 /PRNewswire/ -- VectivBio AG, a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases, today announced it

HOUSTON, Feb. 6, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the appointment of

ALISO VIEJO, Calif., Feb. 6, 2020 /PRNewswire/ -- Metagenics, Inc., a health sciences company, announced today the release of CardioLux HDL, the newest patent pending formula launched in the Metagenics product line. CardioLux HDL provides phytonutrient and vitamin support for healthy HDL function and is designed in partnership with renowned cardiovascular spe

PARIS, Feb. 6, 2020 /PRNewswire/ -- Sanofi (NASDAQ: SNY; EURONEXT: SAN)Q4 2019